ID

42282

Descripción

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. This document is for the Diabetes mellitus sub-cohort. If a text field can't be filled out, note 'ND'.

Link

https://leoss.net

Palabras clave

  1. 30/10/20 30/10/20 -
  2. 1/5/21 1/5/21 -
  3. 27/5/21 27/5/21 - Sarah Riepenhausen
  4. 28/6/21 28/6/21 -
Titular de derechos de autor

LEOSS

Subido en

1 de mayo de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Diabetes mellitus sub-cohort

Diabetes mellitus details
Descripción

Diabetes mellitus details

Alias
UMLS CUI-1
C0011849
UMLS CUI-2
C1522508
Diabetes mellitus type
Descripción

DM type

Tipo de datos

integer

Alias
UMLS CUI [1]
C1320657
Specification of type 3 diabetes mellitus
Descripción

E.g. steroid induced, MODY, pancreatic, NODAT.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441731
UMLS CUI [1,3]
C1521902
Duration of Diabetes mellitus
Descripción

Indicate duration of Diabetes mellitus before diagnosis of SARS-CoV-2.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0449238
Hemoglobin A1c (HbA1c ) in blood
Descripción

Hemoglobin A1c (HbA1c ) in blood

Alias
UMLS CUI-1
C0474680
Hemoglobin A1c (HbA1c ) in blood
Descripción

Indicate values determined closest to the first positive PCR.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0474680
C-peptide in blood
Descripción

C-peptide in blood

Alias
UMLS CUI-1
C0006558
UMLS CUI-2
C0005768
C-peptide in blood at admission day
Descripción

Indicate values determined at admission day.

Tipo de datos

integer

Unidades de medida
  • pmol/l
Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
C-peptide in blood at admission day +1, sober
Descripción

Indicate values determined in blood at next morning after admission, sober.

Tipo de datos

integer

Unidades de medida
  • pmol/l
Alias
UMLS CUI [1,1]
C2208720
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
Glucose in blood
Descripción

Glucose in blood

Alias
UMLS CUI-1
C0392201
Blood glucose level at admission day
Descripción

Indicate values determined at admission day.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1302393
UMLS CUI [1,2]
C0392201
Blood glucose level at admission day +1, fasting glucose
Descripción

Indicate values determined at next morning after admission, fasting glucose.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0428568
UMLS CUI [1,2]
C0332170
UMLS CUI [1,3]
C0687676
UMLS CUI [1,4]
C1302393
C-peptide-to-Glucose Ratio (CGR) in blood
Descripción

C-peptide-to-Glucose Ratio (CGR) in blood

Alias
UMLS CUI-1
C0006558
UMLS CUI-2
C0017725
UMLS CUI-3
C0456603
UMLS CUI-4
C0005768
C-peptide-to-Glucose Ratio (CGR) at admission day
Descripción

Indicate values determined at admission day. C-peptide in (pmol/l); Glucose in (mg/dl).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0017725
UMLS CUI [1,3]
C0456603
UMLS CUI [1,4]
C0005768
UMLS CUI [1,5]
C1302393
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
Descripción

Indicate values determined at next morning after admission, sober. C-peptide in (pmol/l); Glucose in (mg/dl).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0006558
UMLS CUI [1,2]
C0017725
UMLS CUI [1,3]
C0456603
UMLS CUI [1,4]
C0005768
UMLS CUI [1,5]
C0332170
UMLS CUI [1,6]
C0687676
UMLS CUI [1,7]
C1302393
UMLS CUI [1,8]
C0015663
Insulin level in blood
Descripción

Insulin level in blood

Alias
UMLS CUI-1
C0021641
UMLS CUI-2
C0005768
Insulin in blood at admission day
Descripción

Indicate values determined at admission day.

Tipo de datos

integer

Unidades de medida
  • mU/l
Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
Insulin in blood at admission day +1, sober
Descripción

Indicate values determined at next morning after admission, sober.

Tipo de datos

integer

Unidades de medida
  • mU/l
Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
UMLS CUI [1,6]
C0015663
Cortisol level in blood
Descripción

Cortisol level in blood

Alias
UMLS CUI-1
C0201968
UMLS CUI-2
C0005768
Cortisol level in blood at admission day
Descripción

Indicate values determined at admission day.

Tipo de datos

integer

Unidades de medida
  • µg/dl
Alias
UMLS CUI [1,1]
C0201968
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C1302393
Cortisol level in blood at admission day +1, sober
Descripción

Indicate values determined at next morning after admission, sober.

Tipo de datos

integer

Unidades de medida
  • µg/dl
Alias
UMLS CUI [1,1]
C0201968
UMLS CUI [1,2]
C0005768
UMLS CUI [1,3]
C0332170
UMLS CUI [1,4]
C0687676
UMLS CUI [1,5]
C1302393
UMLS CUI [1,6]
C0015663
Has insulin treatment been used before SARS-CoV-2 detection?
Descripción

Has insulin treatment been used before SARS-CoV-2 detection?

Alias
UMLS CUI-1
C0745343
UMLS CUI-2
C0332152
UMLS CUI-3
C5203676
UMLS CUI-4
C1511790
Insulin treatment
Descripción

Indicate insulin treatment before diagnosis of SARS-CoV-2.

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0745343
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C5203676
UMLS CUI [1,4]
C1511790
Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?
Descripción

Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?

Alias
UMLS CUI-1
C0745343
UMLS CUI-2
C4319952
UMLS CUI-3
C0687676
UMLS CUI-4
C5203676
UMLS CUI-5
C1511790
Change of insulin scheme
Descripción

Change of insulin scheme before or after diagnosis of SARS-CoV-2 (+/- 48 h).

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0745343
UMLS CUI [1,2]
C4319952
UMLS CUI [1,3]
C0687676
UMLS CUI [1,4]
C5203676
UMLS CUI [1,5]
C1511790
Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?
Descripción

Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?

Alias
UMLS CUI-1
C0359086
UMLS CUI-2
C0332152
UMLS CUI-3
C5203676
UMLS CUI-4
C1511790
Sulfonylureas
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038766
Metformin
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0025598
GLP-1 analogues
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3273809
DPP-4 blocker
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1827106
SGLT-2 blocker
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3273807
Other treatment
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0359086
Name of other oral antidiabetic treatment
Descripción

Indicate other oral antidiabetic treatment

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0359086
UMLS CUI [1,3]
C1521902
None
Descripción

Indicate treatment before diagnosis of SARS-CoV-2.

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0549184
UMLS CUI [1,2]
C0359086
Unknown
Descripción

Oral antidiabetic treatment, unknown

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C0439673
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Descripción

Is data entry for this section finished?

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197

Similar models

Diabetes mellitus sub-cohort

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Diabetes mellitus details
C0011849 (UMLS CUI-1)
C1522508 (UMLS CUI-2)
Item
Diabetes mellitus type
integer
C1320657 (UMLS CUI [1])
Code List
Diabetes mellitus type
CL Item
Type 1 (1)
CL Item
Type 2 (2)
CL Item
Type 3 (e.g steroid induced, MODY, pancreatic, NODAT) (3)
CL Item
Unknown (4)
Specification of type 3 diabetes mellitus
Item
Specification of type 3 diabetes mellitus
text
C0011849 (UMLS CUI [1,1])
C0441731 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
Item
Duration of Diabetes mellitus
integer
C0011849 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Code List
Duration of Diabetes mellitus
CL Item
<1 year (1)
CL Item
1-10 years (2)
CL Item
> 10 years (3)
CL Item
Unknown (4)
Item Group
Hemoglobin A1c (HbA1c ) in blood
C0474680 (UMLS CUI-1)
Item
Hemoglobin A1c (HbA1c ) in blood
integer
C0474680 (UMLS CUI [1])
Code List
Hemoglobin A1c (HbA1c ) in blood
CL Item
<6.4% (1)
CL Item
6.4% - 8% (2)
CL Item
8.1% - 10% (3)
CL Item
10.1 - 12 % (4)
CL Item
Unknown (5)
Item Group
C-peptide in blood
C0006558 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
C-peptide in blood at admission day
integer
C0006558 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Code List
C-peptide in blood at admission day
CL Item
< 20 pmol/l (1)
CL Item
20-80 pmol/l (2)
CL Item
81-200 pmol/l (3)
CL Item
> 200 pmol/l (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
C-peptide in blood at admission day +1, sober
integer
C2208720 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
Code List
C-peptide in blood at admission day +1, sober
CL Item
< 20 pmol/l (1)
CL Item
20-80 pmol/l (2)
CL Item
81-200 pmol/l (3)
CL Item
> 200 pmol/l (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Glucose in blood
C0392201 (UMLS CUI-1)
Item
Blood glucose level at admission day
integer
C1302393 (UMLS CUI [1,1])
C0392201 (UMLS CUI [1,2])
Code List
Blood glucose level at admission day
CL Item
<100 mg/dl (1)
CL Item
100-126 mg/dl (2)
CL Item
127-200 mg/dl (3)
CL Item
>200 mg/dl (4)
CL Item
Unknown (5)
Item
Blood glucose level at admission day +1, fasting glucose
integer
C0428568 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C1302393 (UMLS CUI [1,4])
Code List
Blood glucose level at admission day +1, fasting glucose
CL Item
<100 mg/dl (1)
CL Item
100-126 mg/dl (2)
CL Item
127-200 mg/dl (3)
CL Item
>200 mg/dl (4)
CL Item
Unknown (5)
Item Group
C-peptide-to-Glucose Ratio (CGR) in blood
C0006558 (UMLS CUI-1)
C0017725 (UMLS CUI-2)
C0456603 (UMLS CUI-3)
C0005768 (UMLS CUI-4)
Item
C-peptide-to-Glucose Ratio (CGR) at admission day
integer
C0006558 (UMLS CUI [1,1])
C0017725 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,3])
C0005768 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
Code List
C-peptide-to-Glucose Ratio (CGR) at admission day
CL Item
<2 (1)
CL Item
2 - 5 (2)
CL Item
>5 (3)
CL Item
Unknown (4)
Item
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
integer
C0006558 (UMLS CUI [1,1])
C0017725 (UMLS CUI [1,2])
C0456603 (UMLS CUI [1,3])
C0005768 (UMLS CUI [1,4])
C0332170 (UMLS CUI [1,5])
C0687676 (UMLS CUI [1,6])
C1302393 (UMLS CUI [1,7])
C0015663 (UMLS CUI [1,8])
Code List
C-peptide-to-Glucose Ratio (CGR) at admission day +1, sober
CL Item
<2 (1)
CL Item
2 - 5 (2)
CL Item
>5 (3)
CL Item
Unknown (4)
Item Group
Insulin level in blood
C0021641 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
Insulin in blood at admission day
integer
C0021641 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Code List
Insulin in blood at admission day
CL Item
< 3 mU/l (1)
CL Item
3-20 mU/l (2)
CL Item
21-200 mU/l (3)
CL Item
> 200 mU/l  (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
Insulin in blood at admission day +1, sober
integer
C0021641 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
C0015663 (UMLS CUI [1,6])
Code List
Insulin in blood at admission day +1, sober
CL Item
< 3 mU/l (1)
CL Item
3-20 mU/l (2)
CL Item
21-200 mU/l (3)
CL Item
> 200 mU/l  (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Cortisol level in blood
C0201968 (UMLS CUI-1)
C0005768 (UMLS CUI-2)
Item
Cortisol level in blood at admission day
integer
C0201968 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Code List
Cortisol level in blood at admission day
CL Item
< 2 µg/dl (1)
CL Item
2-10 µg/dl (2)
CL Item
11-20 µg/dl (3)
CL Item
> 20 µg/dl (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item
Cortisol level in blood at admission day +1, sober
integer
C0201968 (UMLS CUI [1,1])
C0005768 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,4])
C1302393 (UMLS CUI [1,5])
C0015663 (UMLS CUI [1,6])
Code List
Cortisol level in blood at admission day +1, sober
CL Item
< 2 µg/dl (1)
CL Item
2-10 µg/dl (2)
CL Item
11-20 µg/dl (3)
CL Item
> 20 µg/dl (4)
CL Item
Not done (5)
CL Item
Unknown (6)
Item Group
Has insulin treatment been used before SARS-CoV-2 detection?
C0745343 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
C5203676 (UMLS CUI-3)
C1511790 (UMLS CUI-4)
Item
Insulin treatment
integer
C0745343 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C5203676 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,4])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Has the insulin scheme been changed at the time of SARS-CoV-2 detection (+/- 48 h)?
C0745343 (UMLS CUI-1)
C4319952 (UMLS CUI-2)
C0687676 (UMLS CUI-3)
C5203676 (UMLS CUI-4)
C1511790 (UMLS CUI-5)
Item
Change of insulin scheme
integer
C0745343 (UMLS CUI [1,1])
C4319952 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,3])
C5203676 (UMLS CUI [1,4])
C1511790 (UMLS CUI [1,5])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Which oral antidiabetic treatment has been used before SARS-CoV-2 detection?
C0359086 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
C5203676 (UMLS CUI-3)
C1511790 (UMLS CUI-4)
Sulfonylureas
Item
Sulfonylureas
boolean
C0038766 (UMLS CUI [1])
Metformin
Item
Metformin
boolean
C0025598 (UMLS CUI [1])
GLP-1 analogues
Item
GLP-1 analogues
boolean
C3273809 (UMLS CUI [1])
DPP-4 blocker
Item
DPP-4 blocker
boolean
C1827106 (UMLS CUI [1])
SGLT-2 blocker
Item
SGLT-2 blocker
boolean
C3273807 (UMLS CUI [1])
Other oral antidiabetic treatment
Item
Other treatment
boolean
C0205394 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
Indicate other oral antidiabetic treatment
Item
Name of other oral antidiabetic treatment
text
C0205394 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,3])
No oral antidiabetic treatment
Item
None
boolean
C0549184 (UMLS CUI [1,1])
C0359086 (UMLS CUI [1,2])
Oral antidiabetic treatment, unknown
Item
Unknown
boolean
C0359086 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Is data entry for this section finished?
Item
Is data entry for this section finished?
boolean
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial